NCT06021717View on ClinicalTrials.gov

PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

April 4, 2019

Study Completion Date

April 4, 2019

Conditions
KetamineMorphine
Interventions
DRUG

Ketamine-Morphine

PCA ketamine (Ketamine HCl, Pfizer Inc., US) 0.5 mg plus morphine 0.5 mg ml-1 (ratio 1:1)

DRUG

Morphine

PCA morphine (Pfizer Inc., US) 1 mg ml-1

Trial Locations (1)

56000

Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur

All Listed Sponsors
lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER

NCT06021717 - PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery | Biotech Hunter | Biotech Hunter